一个四次击中机制足以导致脑膜瘤的发展
Alex Devarajan1, Carina Seah2, Jack Y Zhang2
1Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. alex.devarajan@icahn.mssm.edu.
Journal of neuro-oncology
|November 25, 2024
概括
良性脑膜瘤发展需要四种基因突变. 这项癌症流行病学研究分析了发病率数据,以确定瘤形成的速度限制步骤,揭示了一致的四步过程.
科学领域:
- 神经瘤学神经瘤学
- 癌症流行病学 癌症流行病学
- 遗传学 遗传学 是一个
背景情况:
- 脑膜瘤是常见的中枢神经系统瘤,其发病率随着年龄的增长而增加.
- 良性脑膜瘤的发展涉及遗传突变 (例如NF2),导致瘤细胞生长.
- 了解速率限制步骤的数量对于建模瘤发育至关重要.
研究的目的:
- 通过癌症流行病学模型研究良性脑膜瘤发展所需的速率限制步骤的数量.
- 应用Armitage-Doll方法来分析发病率数据并识别关键突变事件.
主要方法:
- 使用了非恶性脑膜瘤发病率的监测,流行病学和最终结果 (SEER) 计划数据 (2004-2020年).
- 应用Armitage-Doll方法和多项式回归来模拟年龄调整的发病率.
- 通过75:25的训练:测试分割和分析前置 schwannomas作为对照来验证模型.
主要成果:
- 对222,509例良性脑膜瘤病例的分析显示,日志转换发病率和年龄之间存在强烈的线性关系 (R2=0.99).
- 该模型表明,在各个亚群体中,良性脑膜瘤发展的四步过程.
- 一个经过校正的模型解释了女性患者的非线性偏差,证实了四次成功的途径 (R2=0.99). 静脉 schwannomas 显示了一个三个步骤的过程.
结论:
- 良性脑膜瘤的发展始终需要四种不同的基因突变.
- 这项研究成功地模拟了瘤的发展,并考虑了微环境因素和非线性行为.
- 需要进一步的研究来确定涉及这四步途径的特定基因组突变.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.8K
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K
